TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1642343

Group type: EXPERIMENTAL
Intervention: General Anesthesia (GA)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Epidural Anesthesia (EA)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Cold Ambient Operating Room Temperature
Number of subjects: 97

Group type: COMPARATOR
Intervention: Advancing Patient Age
Number of subjects: 97

Group type: COMPARATOR
Intervention: Warm Ambient Operating Room Temperature
Number of subjects: 97
Study: 3472436

Group type: EXPERIMENTAL
Intervention: Home blood pressure (Home-BP) measured three times daily during a two week period
Number of subjects: 122

Group type: COMPARATOR
Intervention: Out-patient clinic blood pressure (OPC-BP)
Number of subjects: 122
Study: 30393062

Group type: EXPERIMENTAL
Intervention: Antiplatelet treatment
Number of subjects: 2670

Group type: EXPERIMENTAL
Intervention: Statin treatment
Number of subjects: 2670

Group type: EXPERIMENTAL
Intervention: Antiplatelet treatment (users at baseline)
Number of subjects: 2670

Group type: EXPERIMENTAL
Intervention: Statin treatment (users at baseline)
Number of subjects: 2670
Study: 28532863

Group type: EXPERIMENTAL
Intervention: Inhibitory kinesiotaping
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Facilitatory kinesiotaping
Number of subjects: 20

Group type: COMPARATOR
Intervention: Comparison of both interventions
Number of subjects: 20
Study: 26411991

Group type: EXPERIMENTAL
Intervention: Positive Action program
Number of subjects: 1246
Study: 22413736

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural intervention (Internet self-management, bibliotherapy, group training)
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Group training
Number of subjects: 304

Group type: COMPARATOR
Intervention: Control condition (information-only)
Number of subjects: 304
Study: 21708364

Group type: EXPERIMENTAL
Intervention: Laparoscopic computer simulator
Number of subjects: 0

Group type: COMPARATOR
Intervention: Box trainer
Number of subjects: 0
Study: 18452617

Group type: EXPERIMENTAL
Intervention: Diabetes Numeracy Test (DNT)
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: DNT15 (shortened version of DNT)
Number of subjects: 398
Study: 17071217

Group type: EXPERIMENTAL
Intervention: Adherence intervention involving symbolic modeling and vicarious reinforcement
Number of subjects: 128

Group type: COMPARATOR
Intervention: Writing instructions only (Control)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Adherence intervention
Number of subjects: 128
Study: 15301657

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) intervention
Number of subjects: 78

Group type: COMPARATOR
Intervention: Standard psychoeducational counseling
Number of subjects: 78

Group type: COMPARATOR
Intervention: Advice only
Number of subjects: 78
Study: 10952095

Group type: EXPERIMENTAL
Intervention: Brassica vegetable diet
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Apiaceous vegetable diet
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Allium vegetable diet
Number of subjects: 43

Group type: COMPARATOR
Intervention: Vegetable diets (overall)
Number of subjects: 43
Study: 8899382

Group type: COMPARATOR
Intervention: Self-reported exposure to truck traffic (frequent and constant)
Number of subjects: 3703

Group type: COMPARATOR
Intervention: Self-reported exposure to traffic noise
Number of subjects: 3703
Study: 10895736

Group type: EXPERIMENTAL
Intervention: Fluconazole 100 mg tablets once per day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clotrimazole 10 mg troches five times per day
Number of subjects: 0
Study: 3899840

Group type: EXPERIMENTAL
Intervention: Oral indomethacin (total 200 mg) and chloroquine (total 1.5 g)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 29
Study: 3538324

Group type: EXPERIMENTAL
Intervention: SLO4 oral drops
Number of subjects: 60
Study: 31475507

Group type: EXPERIMENTAL
Intervention: Anterior QLB + intravenous PCA morphine (Group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intravenous PCA morphine (Group C)
Number of subjects: 60
Study: 28426917

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive-behavioral therapy (iCBT) program for depression added to treatment as usual (TAU)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 69
Study: 28190255

Group type: EXPERIMENTAL
Intervention: IXEQ2W/IXEQ4W
Number of subjects: 1226

Group type: COMPARATOR
Intervention: IXEQ4W
Number of subjects: 1226

Group type: EXPERIMENTAL
Intervention: IXEQ2W/PBO/IXEQ4W
Number of subjects: 1226

Group type: EXPERIMENTAL
Intervention: IXEQ4W/PBO/IXEQ4W
Number of subjects: 1226
Study: 26021225

Group type: COMPARATOR
Intervention: Protocol A (no other antibiotic administration)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Protocol B (1 g of amoxicillin in the evening of the day of surgery and 1 g twice a day for 2 days after)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Protocol A
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Protocol B
Number of subjects: 360
Study: 23249768

Group type: EXPERIMENTAL
Intervention: Drop jump protocol with 1 set per 5 repetitions
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Drop jump protocol with 2 sets per 5 repetitions
Number of subjects: 10
Study: 21693723

Group type: EXPERIMENTAL
Intervention: Predischarge HF score for subsequent death or unfavorable QoL
Number of subjects: 1458

Group type: EXPERIMENTAL
Intervention: KCCQ scores <45 at 1 and 24 weeks after hospital discharge
Number of subjects: 1458

Group type: EXPERIMENTAL
Intervention: Mortality within 6 months
Number of subjects: 1458
Study: 18803892

Group type: EXPERIMENTAL
Intervention: Intraumbilical vein syntocinon 10 units
Number of subjects: 500

Group type: COMPARATOR
Intervention: Intravenous 5 IU oxytocin + 0.5 mg ergometrine
Number of subjects: 500
Study: 16580284

Group type: EXPERIMENTAL
Intervention: Oral analgesia with oxycodone‐acetaminophen
Number of subjects: 93

Group type: COMPARATOR
Intervention: Morphine patient‐controlled analgesia device
Number of subjects: 93
Study: 14529984

Group type: EXPERIMENTAL
Intervention: 1% lidocaine with epinephrine
Number of subjects: 119

Group type: COMPARATOR
Intervention: Saline with epinephrine
Number of subjects: 119
Study: 10893592

Group type: EXPERIMENTAL
Intervention: 6 biopsy cores
Number of subjects: 244

Group type: COMPARATOR
Intervention: 12 biopsy cores
Number of subjects: 244
Study: 8941068

Group type: EXPERIMENTAL
Intervention: 1,2-propanediol-treated (group 2)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control (group 1)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Cryopreserved (group 3)
Number of subjects: 98
Study: 1357554

Group type: EXPERIMENTAL
Intervention: Salmeterol (42 micrograms twice daily)
Number of subjects: 234

Group type: COMPARATOR
Intervention: Albuterol (180 micrograms four times daily)
Number of subjects: 234

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 234
Study: 3914251

Group type: EXPERIMENTAL
Intervention: Niridazole
Number of subjects: 26

Group type: COMPARATOR
Intervention: Conventional steroid and azathioprine therapy
Number of subjects: 26
Study: 31483884

Group type: EXPERIMENTAL
Intervention: Three-phase integrated weight management programme delivered within routine primary care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Three-phase integrated weight management programme
Number of subjects: 0
Study: 27977284

Group type: EXPERIMENTAL
Intervention: Girls Aspiring toward Independence (GAIN) intervention
Number of subjects: 27

Group type: COMPARATOR
Intervention: Usual care condition
Number of subjects: 27
Study: 25882919

Group type: EXPERIMENTAL
Intervention: Cranberry juice capsules (2 capsules, 2 times a day for 6 weeks)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo (matching placebo, 2 capsules, 2 times a day for 6 weeks)
Number of subjects: 160
Study: 23667192

Group type: EXPERIMENTAL
Intervention: OMT group
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Placebo group
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 53
Study: 21301848

Group type: EXPERIMENTAL
Intervention: Liposomal cisplatin 200 mg/m2 combined with paclitaxel 135 mg/m2
Number of subjects: 202

Group type: COMPARATOR
Intervention: Cisplatin 75 mg/m2 combined with paclitaxel 135 mg/m2
Number of subjects: 202
Study: 19625240

Group type: EXPERIMENTAL
Intervention: Alendronate therapy (10 mg daily)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 17052777

Group type: EXPERIMENTAL
Intervention: Enalapril (50% of CONSENSUS II patients)
Number of subjects: 9915

Group type: COMPARATOR
Intervention: Placebo (control group in CONSENSUS II)
Number of subjects: 9915

Group type: EXPERIMENTAL
Intervention: Neurohormonal blockade (ACEi and beta-blockade in 4S)
Number of subjects: 9915

Group type: COMPARATOR
Intervention: No neurohormonal blockade (control group in 4S)
Number of subjects: 9915
Study: 15045685

Group type: EXPERIMENTAL
Intervention: Glipizide GITS (5 mg/d)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 11684630

Group type: EXPERIMENTAL
Intervention: Carvedilol (nonselective beta-blocker)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Metoprolol (selective beta-blocker)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both carvedilol and metoprolol
Number of subjects: 36

Group type: COMPARATOR
Intervention: Neither carvedilol nor metoprolol
Number of subjects: 36
Study: 14518350

Group type: EXPERIMENTAL
Intervention: Dimetinden/cimetidine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dimetinden/famotidine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dimetinden/ranitidine
Number of subjects: 60
Study: 7814117

Group type: EXPERIMENTAL
Intervention: Application of stannous fluoride (SnF2) and silver diamine fluoride (SDF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Application of stannous fluoride (SnF2) and composite resin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Minimal cavity preparation and composite resin only
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 0
Study: 2773832

Group type: EXPERIMENTAL
Intervention: Dietary cholesterol (equal to about two egg yolks daily)
Number of subjects: 25

Group type: COMPARATOR
Intervention: High saturated fatty acids diet
Number of subjects: 25

Group type: COMPARATOR
Intervention: Modified fat content and fatty acid composition diet
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Dietary cholesterol
Number of subjects: 25
Study: 326215

Group type: EXPERIMENTAL
Intervention: Chlorpromazine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 31407195

Group type: EXPERIMENTAL
Intervention: Boswellic acids (BAs)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 27439382

Group type: EXPERIMENTAL
Intervention: Enhanced 2-hour childbirth education at the maternity hospital
Number of subjects: 659

Group type: COMPARATOR
Intervention: Regular childbirth education
Number of subjects: 659
Study: 25873343

Group type: EXPERIMENTAL
Intervention: FOLFIRI plus endostar
Number of subjects: 40

Group type: COMPARATOR
Intervention: FOLFIRI alone
Number of subjects: 40
Study: 23756230

Group type: EXPERIMENTAL
Intervention: ronacaleret
Number of subjects: 0

Group type: COMPARATOR
Intervention: rhPTH(1‐34)
Number of subjects: 0
Study: 20954591

Group type: EXPERIMENTAL
Intervention: Topography-based LRI
Number of subjects: 36

Group type: COMPARATOR
Intervention: Conventional LRI
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Topography-based LRI and Conventional LRI
Number of subjects: 36
Study: 19437505

Group type: EXPERIMENTAL
Intervention: Internet‐based cognitive‐behavioral treatment with minimal contact via e‐mail
Number of subjects: 52

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 52
Study: 17059385

Group type: EXPERIMENTAL
Intervention: Raloxifene
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 0
Study: 15311111

Group type: EXPERIMENTAL
Intervention: Examination of individual serial echocardiograms
Number of subjects: 210

Group type: COMPARATOR
Intervention: Examination of all-patient mixed echocardiograms
Number of subjects: 210
Study: 11758074

Group type: EXPERIMENTAL
Intervention: Quality improvement interventions (development and promulgation of clinical practice guidelines combined with regular audit and feedback)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quality improvement interventions
Number of subjects: 0
Study: 9389841

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 13

Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 13
Study: 8186348

Group type: EXPERIMENTAL
Intervention: Propranolol 160 mg long-acting (LA)
Number of subjects: 319

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 319
Study: 3283917

Group type: EXPERIMENTAL
Intervention: Cimetidine, 400 mg twice daily
Number of subjects: 118

Group type: COMPARATOR
Intervention: Novaluzid, 10 ml four times daily
Number of subjects: 118
Study: 30146148

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Active Control Condition (ACC)
Number of subjects: 92
Study: 28661435

Group type: EXPERIMENTAL
Intervention: Thiamine fortification
Number of subjects: 196
Study: 25645436

Group type: EXPERIMENTAL
Intervention: Patellar tendon graft
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Hamstrings tendon graft
Number of subjects: 68

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 68
Study: 23900048

Group type: EXPERIMENTAL
Intervention: Dynamic positron emission tomography imaging with (18)FDG
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Dicholoroacetate and 2 tyrosine kinase inhibitors (imatinib and sunitinib)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Dicholoroacetate and imatinib
Number of subjects: 20
Study: 21138902

Group type: EXPERIMENTAL
Intervention: Neutral shoulder position
Number of subjects: 361

Group type: COMPARATOR
Intervention: Lowered shoulder position
Number of subjects: 361
Study: 18978612

Group type: COMPARATOR
Intervention: Treadmill running (TR) test
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cross-country roller-skiing (RS) test
Number of subjects: 10
Study: 17136615

Group type: EXPERIMENTAL
Intervention: Videoconferencing
Number of subjects: 581

Group type: EXPERIMENTAL
Intervention: Online learning
Number of subjects: 581

Group type: COMPARATOR
Intervention: Conference lectures
Number of subjects: 581

Group type: COMPARATOR
Intervention: Instructor-led small group outreach sessions
Number of subjects: 581
Study: 14737728

Group type: EXPERIMENTAL
Intervention: 0.5‐1cm deep marker injection
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sub‐epithelial marker injection
Number of subjects: 60
Study: 10632651

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg, Amoxycillin 1 g, and Clarithromycin 500 mg (OAC) b.d. for 1 week
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Quadruple therapy (Bismuth subcitrate 120 mg, Tetracycline 500 mg, Metronidazole 400 mg q.d.s. plus Omeprazole 20 mg b.d.)
Number of subjects: 398
Study: 8959612

Group type: EXPERIMENTAL
Intervention: Focused stimulation intervention administered by parents
Number of subjects: 25

Group type: COMPARATOR
Intervention: Delayed-treatment (control) group
Number of subjects: 25
Study: 7934140

Group type: EXPERIMENTAL
Intervention: Cisplatin treatment in vitro
Number of subjects: 14

Group type: COMPARATOR
Intervention: Mitoxantrone, cytosine arabinoside ± carboplatin
Number of subjects: 14
Study: 3287592

Group type: EXPERIMENTAL
Intervention: Insulin infusion at a rate of 2 mU/kg/min with concomitant glucose infusion to maintain euglycaemia
Number of subjects: 8

Group type: COMPARATOR
Intervention: Insulin infusion with falling blood glucose (no glucose infusion)
Number of subjects: 8
Study: 31806733

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided lumbar puncture
Number of subjects: 77

Group type: COMPARATOR
Intervention: Landmark-based lumbar puncture
Number of subjects: 77
Study: 31574581

Group type: EXPERIMENTAL
Intervention: Severe uncorrected refractive error in non-Indigenous Australians
Number of subjects: 4836

Group type: EXPERIMENTAL
Intervention: Severe uncorrected refractive error in Indigenous Australians
Number of subjects: 4836

Group type: EXPERIMENTAL
Intervention: Older age (70-79 years) in Indigenous Australians
Number of subjects: 4836

Group type: EXPERIMENTAL
Intervention: Residing in outer regional areas in Indigenous Australians
Number of subjects: 4836

Group type: EXPERIMENTAL
Intervention: Not having an eye examination in the previous 2 years in Indigenous Australians
Number of subjects: 4836

Group type: EXPERIMENTAL
Intervention: Geographical remoteness in non-Indigenous Australians
Number of subjects: 4836

Group type: EXPERIMENTAL
Intervention: Male gender in non-Indigenous Australians
Number of subjects: 4836

Group type: EXPERIMENTAL
Intervention: Older age (70-79 years) in non-Indigenous Australians
Number of subjects: 4836

Group type: EXPERIMENTAL
Intervention: Not having an eye examination in the previous 2 years in non-Indigenous Australians
Number of subjects: 4836
Study: 29446784

Group type: EXPERIMENTAL
Intervention: Opaque sealant
Number of subjects: 42

Group type: COMPARATOR
Intervention: Clear sealant
Number of subjects: 42
Study: 28032151

Group type: EXPERIMENTAL
Intervention: Two septocolumellar sutures (Group-1)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Columellar strut graft (Group-2)
Number of subjects: 44
Study: 25958154

Group type: EXPERIMENTAL
Intervention: Smartphone application (AliveCor) using position PI (horizontal)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Smartphone application (AliveCor) using position PII (rotated 60° clockwise)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Smartphone application (AliveCor) using position PIII (rotated 120° clockwise)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Comparison of position PII vs. PIII
Number of subjects: 37
Study: 24293773

Group type: EXPERIMENTAL
Intervention: 1,630 m altitude exposure
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 2,590 m altitude exposure
Number of subjects: 51

Group type: COMPARATOR
Intervention: 490 m altitude exposure (control)
Number of subjects: 51
Study: 21276534

Group type: EXPERIMENTAL
Intervention: Mental Practice (MP) for 30 minutes before each laparoscopic cholecystectomy (LC)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Mental Practice (MP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (unrelated activity)
Number of subjects: 20
Study: 19221908

Group type: EXPERIMENTAL
Intervention: Computerized prevention programme
Number of subjects: 764

Group type: COMPARATOR
Intervention: Usual classes
Number of subjects: 764
Study: 17032123

Group type: EXPERIMENTAL
Intervention: Bioabsorbable membrane (RXT group)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Bioactive glass (PG group)
Number of subjects: 16
Study: 12595281

Group type: EXPERIMENTAL
Intervention: Diuretic (Hypo; 100 mg/day spironolactone for 3 days)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (Normo)
Number of subjects: 8
Study: 10992369

Group type: EXPERIMENTAL
Intervention: Screening arm
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: General population
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Digital rectal examination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Former PSA testing or digital rectal examination
Number of subjects: 0
Study: 7671058

Group type: EXPERIMENTAL
Intervention: Sufentanil
Number of subjects: 30

Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 30
Study: 2360466

Group type: EXPERIMENTAL
Intervention: Antiepileptic drugs (AEDs) as prophylactic treatment
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Continuation of AEDs after surgery in patients with preoperative epilepsy
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: No long-term AEDs treatment in patients without preoperative epilepsy
Number of subjects: 128
Study: 7302369

Group type: EXPERIMENTAL
Intervention: Glipizide (5 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 31126208

Group type: EXPERIMENTAL
Intervention: TAP hydrogel
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline (Control)
Number of subjects: 60
Study: 28288074

Group type: EXPERIMENTAL
Intervention: DXA test results provided directly to patients
Number of subjects: 4525
Study: 25887586

Group type: EXPERIMENTAL
Intervention: Femoral neck osteotomy guide
Number of subjects: 48

Group type: COMPARATOR
Intervention: No femoral neck osteotomy guide
Number of subjects: 48
Study: 23398608

Group type: EXPERIMENTAL
Intervention: High-frequency rTMS (10 Hz, 20 min, total 2,000 pulses)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham stimulation (20 min)
Number of subjects: 18
Study: 21883158

Group type: EXPERIMENTAL
Intervention: Inclusion norm
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: Exclusion norm
Number of subjects: 383

Group type: COMPARATOR
Intervention: School inclusion norm
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: Exclusion-plus-relational aggression norm
Number of subjects: 383
Study: 18498003

Group type: EXPERIMENTAL
Intervention: Drug-eluting stents (DES)
Number of subjects: 4351

Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 4351
Study: 17597050

Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg once daily
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 15114776

Group type: EXPERIMENTAL
Intervention: Postoperative intravesicular immunotherapy with ronkoleucine 1,000,000 IU
Number of subjects: 30

Group type: COMPARATOR
Intervention: Postoperative intravesicular immunotherapy with ronkoleucine 500,000 IU
Number of subjects: 30
Study: 11407666

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary angioplasty + Helicobacter pylori eradication therapy
Number of subjects: 240

Group type: COMPARATOR
Intervention: Percutaneous coronary angioplasty + placebo treatment
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Helicobacter pylori seropositivity in coronary artery disease patients
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Cytotoxin associated gene A IgG detection in coronary artery disease patients
Number of subjects: 240
Study: 9728837

Group type: EXPERIMENTAL
Intervention: IV lidocaine 2 mg/kg
Number of subjects: 65
Study: 9185632

Group type: COMPARATOR
Intervention: Registry patients (CABG)
Number of subjects: 842

Group type: COMPARATOR
Intervention: Registry patients (PTCA)
Number of subjects: 842

Group type: COMPARATOR
Intervention: Randomized patients (CABG)
Number of subjects: 842

Group type: COMPARATOR
Intervention: Randomized patients (PTCA)
Number of subjects: 842

Group type: EXPERIMENTAL
Intervention: Registry PTCA
Number of subjects: 842

Group type: EXPERIMENTAL
Intervention: Registry CABG
Number of subjects: 842